Biocon Chief Extols Moderna’s Success To Spur ‘Risk-Averse’ VCs in India

 
• By Anju Ghangurde

Biocon chairperson Kiran Mazumdar-Shaw says that venture capital firms have, with their risk-averse approach, "failed" the biotech sector in India. The executive draws attention to how "bold" venture funds that backed mRNA technology a decade ago were reaping gains today.

Kiran Mazumdar Shaw
Biocon Chief Kiran Mazumdar-Shaw • Source: Alamy

More from Business

More from Scrip